| Myelodysplastic Syndrome with Ring Sideroblasts studied in …STUDIED_INderived10 of 21show all (up to 200) |
|---|
| → studied in | NCT00392353Phase 1/Phase 2 · active not recruiting Vorinostat and Azacitidine in Treating Patients With Myelodysplastic Syndromes or Acute Myeloid Leukemia · condition mapped ONTOLOGY_EXACT · 21 trials mapped (2 active) | — | — | Myelodysplastic Syndrome with Ring Sideroblasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04869683NA · recruiting Biocollection in MyeloDysplastic Syndrome (P-MDS) · condition mapped ONTOLOGY_EXACT · 21 trials mapped (2 active) | — | — | Myelodysplastic Syndrome with Ring Sideroblasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01384513Phase 2 · completed A Two-Step Approach to Reduced Intensity Bone Marrow Transplant for Patients With Hematological Malignancies · condition mapped ALIAS · 21 trials mapped (2 active) | — | — | Myelodysplastic Syndrome with Ring Sideroblasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02566304Phase 2 · completed Reduced Intensity Chemotherapy and Radiation Therapy Before Donor Stem Cell Transplant in Treating Patients With Hematologic Malignancies · condition mapped ALIAS · 21 trials mapped (2 active) | — | — | Myelodysplastic Syndrome with Ring Sideroblasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00589316Phase 1 · terminated Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Cyclophosphamide, Total-Body Irradiation and Donor Bone Marrow Transplant in Treating Patients With Advanced Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or High-Risk Myelodysplastic Syndrome · condition mapped ALIAS · 21 trials mapped (2 active) | — | — | Myelodysplastic Syndrome with Ring Sideroblasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00119366Phase 2 · terminated Iodine I 131 Monoclonal Antibody BC8, Fludarabine Phosphate, Total Body Irradiation, and Donor Stem Cell Transplant Followed by Cyclosporine and Mycophenolate Mofetil in Treating Patients With Advanced Acute Myeloid Leukemia or Myelodysplastic Syndrome · condition mapped ALIAS · 21 trials mapped (2 active) | — | — | Myelodysplastic Syndrome with Ring Sideroblasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00397813Phase 2 · completed Fludarabine Phosphate and Total Body Irradiation Followed by a Donor Peripheral Stem Cell Transplant in Treating Patients With Myelodysplastic Syndromes or Myeloproliferative Disorders · condition mapped ALIAS · 21 trials mapped (2 active) | — | — | Myelodysplastic Syndrome with Ring Sideroblasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00078858Phase 1/Phase 2 · completed Mycophenolate Mofetil and Cyclosporine in Reducing Graft-Versus-Host Disease in Patients With Hematologic Malignancies or Metastatic Kidney Cancer Undergoing Donor Stem Cell Transplant · condition mapped ALIAS · 21 trials mapped (2 active) | — | — | Myelodysplastic Syndrome with Ring Sideroblasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00027820Phase 1/Phase 2 · completed Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer · condition mapped ALIAS · 21 trials mapped (2 active) | — | — | Myelodysplastic Syndrome with Ring Sideroblasts | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01012492Phase 2 · completed Pilot of Abatacept-based Immunosuppression for Prevention of Acute GvHD During Unrelated Donor HCT · condition mapped ALIAS · 21 trials mapped (2 active) | — | — | Myelodysplastic Syndrome with Ring Sideroblasts | 1 | Observed | clinicaltrials | graph → |